Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

287 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A one health framework to estimate the cost of antimicrobial resistance.
Morel CM, Alm RA, Årdal C, Bandera A, Bruno GM, Carrara E, Colombo GL, de Kraker MEA, Essack S, Frost I, Gonzalez-Zorn B, Goossens H, Guardabassi L, Harbarth S, Jørgensen PS, Kanj SS, Kostyanev T, Laxminarayan R, Leonard F, Hara GL, Mendelson M, Mikulska M, Mutters NT, Outterson K, Baňo JR, Tacconelli E, Scudeller L; GAP-ON€ network. Morel CM, et al. Among authors: mikulska m. Antimicrob Resist Infect Control. 2020 Nov 26;9(1):187. doi: 10.1186/s13756-020-00822-6. Antimicrob Resist Infect Control. 2020. PMID: 33243302 Free PMC article.
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study.
Albasanz-Puig A, Gudiol C, Parody R, Tebe C, Akova M, Araos R, Bote A, Brunel AS, Calik S, Drgona L, García E, Hemmati P, Herrera F, Ibrahim KY, Isler B, Kanj S, Kern W, Maestro de la Calle G, Manzur A, Marin JI, Márquez-Gómez I, Martín-Dávila P, Mikulska M, Montejo JM, Montero M, Morales HMP, Morales I, Novo A, Oltolini C, Peghin M, Del Pozo JL, Puerta-Alcalde P, Ruiz-Camps I, Sipahi OR, Tilley R, Yáñez L, Gomes MZR, Carratalà J; IRONIC study group. Albasanz-Puig A, et al. Among authors: mikulska m. BMJ Open. 2019 May 24;9(5):e025744. doi: 10.1136/bmjopen-2018-025744. BMJ Open. 2019. PMID: 31129580 Free PMC article.
Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
Gudiol C, Albasanz-Puig A, Laporte-Amargós J, Pallarès N, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martín-Dávila P, Herrera F, Gasch O, Drgona L, Paz Morales H, Brunel AS, García E, Isler B, Kern WV, Morales I, Maestro-de la Calle G, Montero M, Kanj SS, Sipahi OR, Calik S, Márquez-Gómez I, Marin JI, Gomes MZR, Hemmatti P, Araos R, Peghin M, Del Pozo JL, Yáñez L, Tilley R, Manzur A, Novo A, Carratalà J; IRONIC Study Group. Gudiol C, et al. Among authors: mikulska m. Antimicrob Agents Chemother. 2020 Mar 24;64(4):e02494-19. doi: 10.1128/AAC.02494-19. Print 2020 Mar 24. Antimicrob Agents Chemother. 2020. PMID: 32015035 Free PMC article.
Prospective multicentre study on azole resistance in Aspergillus isolates from surveillance cultures in haematological patients in Italy.
Prigitano A, Esposto MC, Grancini A, Passera M, Paolucci M, Stanzani M, Sartor A, Candoni A, Pitzurra L, Innocenti P, Micozzi A, Cascio GL, Delia M, Mosca A, Mikulska M, Ossi C, Fontana C, Pizzolante M, Gelmi M, Cavanna C, Lallitto F, Amato G, Vella A, Pagano L, Bandettini R, De Lorenzis G, Cogliati M, Romanò L, Tortorano A. Prigitano A, et al. Among authors: mikulska m. J Glob Antimicrob Resist. 2020 Sep;22:231-237. doi: 10.1016/j.jgar.2020.01.016. Epub 2020 Feb 13. J Glob Antimicrob Resist. 2020. PMID: 32061880 Free article.
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab.
Zappulo E, Nicolini LA, Di Grazia C, Dominietto A, Lamparelli T, Gualandi F, Caligiuri P, Bruzzone B, Angelucci E, Viscoli C, Mikulska M. Zappulo E, et al. Among authors: mikulska m. Infection. 2019 Feb;47(1):59-65. doi: 10.1007/s15010-018-1214-5. Epub 2018 Sep 19. Infection. 2019. PMID: 30232604
Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors.
Royo-Cebrecos C, Laporte-Amargós J, Peña M, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martín-Dávila P, Herrera F, Gasch O, Drgona L, Morales HMP, Brunel AS, García E, Isler B, Kern WV, Palacios-Baena ZR, de la Calle GM, Montero MM, Kanj SS, Sipahi OR, Calik S, Márquez-Gómez I, Marin JI, Gomes MZR, Hemmatti P, Araos R, Peghin M, Del Pozo JL, Yáñez L, Tilley R, Manzur A, Novo A, Carratalà J, Gudiol C; IRONIC study group. Royo-Cebrecos C, et al. Among authors: mikulska m. Pathogens. 2022 Sep 30;11(10):1132. doi: 10.3390/pathogens11101132. Pathogens. 2022. PMID: 36297188 Free PMC article.
Triple antiviral treatment for COVID-19 in an immunocompromised patient.
Dentone C, Mikulska M, Sepulcri C, Balletto E, De Pace V, Beltramini S, Bassetti M. Dentone C, et al. Among authors: mikulska m. J Antimicrob Chemother. 2023 Aug 2;78(8):2097-2099. doi: 10.1093/jac/dkad159. J Antimicrob Chemother. 2023. PMID: 37229548 No abstract available.
287 results